Buprenorphine vs Trastuzumab

Buprenorphine vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Buprenorphine and Trastuzumab.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Buprenorphine — 24-42 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Buprenorphine — C29H41NO4.

Molecular Weight: Buprenorphine — 467.6430 g/mol.

Type: Buprenorphine — Small molecule; Trastuzumab — Antibody.